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Background
Within the field of radiotherapy, modern radiation oncology relies on high precision imaging
techniques like Computed Tomography (CT), Positron Emitting Tomography (PET) and
Magnetic Resonance Imaging (MRI) in order to deliver high radiation doses to precisely
defined targets [1-3]. Tumors undergoing fractionated radiation therapy rarely display a fixed
position during irradiation or within treatment, due to changes in organ filling, breathing
motion and tumor size. This usually entails that the planning target volume has to be
increased to ensure radiation dose coverage during treatment [4].
Image-guided Radiotherapy (IGRT) is a recently developed technique that has contributed to
decrease in planning target volume, as 2D - and 3D images are frequently recorded before
and during treatment [1,5]. This protocol has reduced treatment toxicity and improved
relapse-free survival [6]. However, a remaining challenge within IGRT is fixation and
correlation of the anatomical positions of several tumors to internal fixation points such as
the skeleton. Radiopaque fiducial tissue markers (contrast agents) are therefore implanted
near or inside the tumor to facilitate precise localization of tumors during therapy and
thereby increase radiation accuracy. Solid markers like gold seeds are used routinely as
radiopaque markers due to their excellent radiographic contrast, but the implantation
procedure may cause severe complications [7]. Migration of seeds is likewise an issue. As an
alternative, liquid fiducial markers are therefore of high interest.
Based on our previous work [8] - the work presented in this poster deals with development
of biocompatible liquid fiducial injectable markers based upon well-defined coated gold
nanoparticles (AuNPs) encapsulated within a secondary medium of sucrose acetate
isobutyrate (SAIB), PLA (poly-lactic acid) and EtOH (Figure 1). The mixture of PLA, EtOH, SAIB
and coated AuNPs forms a Newtonian liquid (50-200 mPa⋅s) that is injectable through thin,
hypodermic needles (25 G). Upon injection, efflux of EtOH via non-solvent induced phase
separation (NIPS) occurs, leading to the formation of a highly viscous, hydrophobic fiducial
radiopaque implant.
Experimental methods
The AuNPs were synthesized by a three step seeding protocol using chloroauric acid and
trisodium citrate (Scheme 1). Three different coating options were tested: 1) Thiol-
terminated PEG5000 polymers, 2) thiol-terminated PNIPAM3500 polymers and 3) a dithiolane
functionalized SAIB derivative that was synthesized in 4 steps from sucrose.
The AuNP-SAIB gels were made by dispersing the coated AuNPs in EtOH follwed by mixing
with SAIB and PLA. In vitro stability studies of AuNP-SAIB gels were conducted in PBS-buffer
at 370C. In vivo contrast and stability of the gels were monitored by micro-CT after injection
of 200μL of SAIB/EtOH/PLA (75:20:5) + 30mg∙mL-1 PNIPAM-AuNPs or 10mg∙mL-1 PEG-AuNPs
at the upper left flank of immunocompetent NMRI-mice. The X-ray contrast level, gel volume
and gel homogeneity were evaluated over time by active contour model.
Results
Stable and uniform PEG - and PNIPAM-coated AuNPs were successfully synthesized, confer
Figure 2. The dithiolane SAIB functionalized AuNPs were discarded due to observed
aggregation of the nanoparticles. In-vitro stability test of the PEG-AuNP-SAIB gel (Figure 3)
showed rapid burst release of PEGylated AuNPs. This burst release was completely avoided
(<1%) with the PNIPAM-AuNP-SAIB gel, even with concentrations up to 100mg∙mL-1.
In vivo contrast and stability of the PEG- and PNIPAM-AuNP-SAIB gels were likewise analyzed.
The PEG-AuNP-SAIB gel suffered from PEG-AuNP migration towards the gel-boundaries over
time [8]. Figure 4 and 5 show micro-CT scans of mice after injection of the PNIPAM-AuNP-SAIB
gel. The PNIPAM-AuNP-SAIB gel provided high stability in vivo, as well as a higher X-ray
contrast level than the PEGylated AuNP-SAIB gel (as expected due to higher AuNP loading
being possible with the PNIPAM coating).
The contrast level and homogeneity of the gels were analyzed manually in each CT scanning
slice. First, a bounding box was drawn around each gel, and the gels were segmented by active
contour model [9]. The median values of the two gel types were compared using a Wilcoxon
rank-sum test [10]. The homogeneity of the gels was then analyzed by first applying a Box-Cox
transformation [11] to the two datasets for variance stabilization, followed by a Wilcoxon rank
sum test for comparison of variance.
The PNIPAM-AuNP-SAIB gel had a significantly higher median (P-value: 0.0006) as expected
due to higher loading of AuNPs. Despite a much better contrast, surprisingly no significant
difference was found in the variance of the gels (P-value: 0.0734), thereby indicating the same
extent of inhomogeneity in the PNIPAM-AuNP-SAIB gel and the PEG-AuNP-SAIB gel. This is due
to the inhomogeneity only being visible at higher intensity levels (Figure 5). Due to the much
lesser resolution in clinical imaging systems, the slight inhomogeneity of the PNIPAM-AuNP-
SAIB gel will not be visible and will therefore not be an issue in clinical applications.
Handling of PNIPAM-coated AuNPs was furthermore superior to the PEGylated AuNPs, as they
can be lyophilized and stored as a stable powder, that is easily dispersible in EtOH. Based on
the presented in vitro and in vivo results, the PNIPAM-AuNP-SAIB gel was evaluated to be
suitable as tissue marker for IGRT.
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Figure 3.  In vitro release in PBS-buffer at 37°C 
from SAIB/EtOH/PLA (75:20:5)  containing either 
30mg∙mL-1 PNIPAM-AuNPs (blue)  or 30mg∙mL-1
PEGylated-AuNPs (red)
Figure 4. Maximum Intensity Projection of a 
PNIPAM-AuNP-SAIB gel–depot viewed from 
several angles
Figure 1.  Principle of  the developed liquid fiducial marker.
Figure 5. Micro-CT scanning slice of the PNIPAM-
AuNP-SAIB gel in a mouse at three contrast levels. 
At high contrast level, slight inhomogeneity in the 
AuNP distribution is observed
Figure 2. From left to right: UV-Vis -, DLS – and
ζ-potential characterization of PEG-, PNIPAM- and
dithiolane-SAIB coated AuNPs in aqueous solution 
Scheme 1. Synthesis of PEG-, PNIPAM- and SAIB-coated AuNPs
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The poster presents the development of a liquid fiducial tissue marker based on sucrose acetate isobutyrate (SAIB) and uniform, coated gold nanoparticles (AuNPs). The 
PNIPAM-coated AuNP-SAIB gel provided high CT contrast and high in vivo stability and was assessed to be a suitable tissue marker for image guided radiotherapy (IGRT).
